Loading chat...
DE SB129
Bill
Status
7/21/2025
Primary Sponsor
Stephanie Hansen
Click for details
AI Summary
-
Expands the definition of "statewide opioid settlement agreement" to include settlements with individuals and entities controlled by those individuals, in addition to corporations and other business entities
-
Bars government entities from asserting released claims against individuals or other persons (not just entities) who have been released by the Department of Justice in opioid settlement agreements
-
Addresses a gap created by the 2024 U.S. Supreme Court ruling that prevented Sackler family members from obtaining bankruptcy-style discharge, requiring a non-bankruptcy settlement approach
-
Enables Delaware to finalize a settlement-in-principle reached with Purdue Pharma and the Sackler family announced on January 23, 2025
-
Amends the Prescription Opioid Impact Fund framework established by Senate Bill 166 in 2022 to maximize settlement funds Delaware receives from individual defendants like the Sackler family
Legislative Description
An Act To Amend Title 16 Of The Delaware Code Relating To Prescription Opioid Funds And Litigation Authority.
Last Action
Signed by Governor
7/21/2025